Reckitt strikes deal worth up to £3.6bn to sell Cillit Bang business
Reckitt will keep a 30% stake in the essential home business after the sale, with up to 1.3 billion dollars (£968 million) deferred under the deal.
It will offload six factories, including a site in Derby, to Advent under the deal.
The firm will also book around 800 million dollars (£596 million) in costs for splitting out the essential home division from the rest of the business.
It expects to complete the deal by the end of the year.
Kris Licht, Reckitt chief executive, said: 'We are executing our strategic plan at pace.
'The divestment of Essential Home represents a significant step forward in unlocking the substantial value in our business.
'This moves Reckitt towards becoming a simpler, more effective world-class consumer health and hygiene company and it will enable us to focus on a core portfolio of high-growth, high-margin power brands.'
It put the essential home division, which accounts for about 14% of group net revenues, up for sale last summer as part of a major overhaul.
Mr Licht has been leading a plan to restructure Reckitt, unveiling aims last year to spin off its baby formula business, Mead Johnson, and sell the essential home division to focus on 'power brands', such as Durex condoms, Gaviscon antacid and Strepsils lozenges.
The essential home business delivered around £2 billion of net revenues in 2024 and it made underlying earnings of £486 million in the year to March.
Reckitt said the sale would help further boost shareholder returns, with it set to pay out a 2.2 billion dollar (£1.6 billion) special dividend to investors.
The group added it plans to offset the costs of spinning off the division under wider aims to cut costs across the firm.
Shares in Reckitt lifted 2% in morning trading on Friday.
Ranjan Sen, managing partner of Advent said: 'The carve-out represents a unique opportunity to create a focused, scaled platform of globally recognised home care brands that operate in attractive categories.
'We are confident we can build on the portfolio's strong foundations to drive operational excellence and unlock the brands' full potential.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
8 hours ago
- Daily Mail
Spectris agrees £4.8bn takeover offer as KKR outbids private equity rival
Private equity giant KKR has trumped rival Advent's takeover bid for British scientific instruments maker Spectris with an improved offer. The two US firms have been battling for control of the FTSE 250 firm since it agreed to an initial £37.63 per Spectris share bid from Advent in June. Spectris withdrew its support for an Advent bid valuing its shares at £41 each on Tuesday, and backed a sweetened KKR offer of £41.75 per share instead. The offer values Spectris' equity at £4.2billion, with an enterprise value of £4.8billion. New York buyout group KKR was dubbed the 'barbarians at the gate' for its fearsome reputation following a 1989 takeover of RJR Nabisco, which was turned into a book and film. It marks another major blow to Britain's public markets, which are on course for the biggest year of takeovers since 2021 after £74billion of offers in the first half, according to Peel Hunt. Spectris directors unanimously recommended KKR's latest offer, which they said was 'fair and reasonable' and 'in the best interests' of shareholders. Spectris shares have more than doubled since Advent's initial bid in June, propelled by the bidding war, and closed at 4,140p on Monday evening. KKR's latest bid values the firm at a 104.9 per cent premium to Spectris' closing share price of £20.38 on 6 June 2025 when Advent's initial bid was made. The firm's latest offer comprises £40.72 in cash and an interim dividend of 28p per Spectris Share. Investors will have to approve the deal at an upcoming meeting before it can go ahead.
Reuters
8 hours ago
- Reuters
UK's Spectris agrees sweetened KKR offer as takeover battle heats up
LONDON, Aug 5 (Reuters) - British scientific instruments maker Spectris (SXS.L), opens new tab has agreed to a sweetened offer from U.S. private equity firm KKR (KKR.N), opens new tab valuing it at 4.8 billion pounds ($6.4 billion), it said on Tuesday, withdrawing its backing for a lower offer from rival suitor Advent. The London-headquartered company said it had agreed to a 41.75 pound per share deal with KKR just four days after backing a bid from Advent at 41 pound per share. Shares in Spectris gained 1.4% in early trading. The two private equity firms have been vying for control of the company for over a month after Spectris agreed to an initial offer from Advent in June. Britain's subdued valuations and relative stability have attracted overseas buyers, with a flurry of bids in recent months highlighting appetite for UK assets. Advent's initial bid came after Spectris' share price had declined by around half from a 2021 peak. The KKR offer values Spectris' equity at 4.2 billion pounds, with an enterprise value of 4.8 billion pounds including debt. The pace of takeovers of British companies has accelerated this year despite the turmoil triggered by U.S. tariffs, which weighed on global dealmaking in the months after so-called Liberation Day in early April. There has since been a rebound, with the value of transactions in the first seven months of the year reaching $2.6 trillion, the highest for the period since the 2021 pandemic-era peak, according to data from Dealogic. ($1 = 0.7528 pounds)
Reuters
10 hours ago
- Reuters
UK's Spectris agrees to $5.6 billion offer from KKR as takeover battle heats up
Aug 5 (Reuters) - UK scientific instruments maker Spectris (SXS.L), opens new tab has agreed to a sweetened offer from U.S. firm KKR (KKR.N), opens new tab valuing it at 4.2 billion pounds ($5.57 billion), it said on Tuesday, withdrawing its backing for a lower offer from rival suitor Advent. ($1 = 0.7534 pounds)
